Implication of Polymorphisms in DNA Repair Genes in Prognosis of Hepatocellular Carcinoma |
Yue, Ai-Min
(Department of Surgical Oncology, Xinxiang Central Hospital)
Xie, Zhen-Bin (Department of Surgical Oncology, Xinxiang Central Hospital) Guo, Shu-Ping (Department of Surgical Oncology, Xinxiang Central Hospital) Wei, Qi-Dong (Department of Surgical Oncology, Xinxiang Central Hospital) Yang, Xiao-Wei (Department of Surgical Oncology, Xinxiang Central Hospital) |
1 | Manuguerra M, Saletta F, Karagas MR, et al (2006). XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am J Epidemiol, 164, 297-302. DOI ScienceOn |
2 | Pang R, Tse E, Poon RT (2006). Molecular pathways in hepatocellular carcinoma. Cancer Lett, 240, 157-69. DOI ScienceOn |
3 | Ramachandran S, Ramadas K, Hariharan R (2006). Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncol, 42, 350-62. DOI ScienceOn |
4 | Rybarova S, Vecanova J, Hodorova I, et al (2011). Association between polymorphisms of XRCC1, p53 and MDR1 genes, the expression of their protein products and prognostic significance in human breast cancer. Med Sci Monit, 17, BR354-63. |
5 | Shen MR, Jones IM, Mohrenweiser H (1998). Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer research, 58, 604-8. |
6 | Slyskova J, Naccarati A, Pardini B, et al (2012). Differences in nucleotide excision repair capacity between newly diagnosed colorectal cancer patients and healthy controls. Mutagenesis, 27, 225-32. DOI ScienceOn |
7 | Smith TR, Miller MS, Lohman K, et al (2003). Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett, 190, 183-90. DOI ScienceOn |
8 | Xu C, Wang X, Zhang Y, et al (2011). Effect of the XRCC1 and XRCC3 genetic polymorphisms on the efficacy of platinum-based chemotherapy in patients with advanced non-small cell lung cancer. Zhongguo Fei Ai Za Zhi, 14, 912-7. |
9 | Yu MW, Yang SY, Pan IJ, et al (2003). Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst, 95, 1485-8. DOI ScienceOn |
10 | Zhang H, Li W, Franklin MJ, et al (2011). Polymorphisms in DNA repair gene XRCC1 and skin cancer risk: a meta-analysis. Anticancer Res, 31, 3945-52. |
11 | Azad AK, Bairati I, Samson E, et al (2012). Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival. Clin Cancer Res, 18, 196-206. DOI ScienceOn |
12 | Benhamou S, Sarasin A (2002). ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis, 17, 463-9. DOI ScienceOn |
13 | Biason P, Hattinger CM, Innocenti F, et al (2012). Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy. Pharmacogenomics J, 12, 476-83. DOI ScienceOn |
14 | Bowen DG, Walker CM (2005). Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature, 436, 946-52. DOI ScienceOn |
15 | Chen X, Sun H, Ren S, et al (2012). Association of XRCC3 and XPD751 SNP with efficacy of platinum-based chemotherapy in advanced NSCLC patients. Clin Transl Oncol, 14, 207-13. DOI |
16 | International Agency for Research on Cancer (2011). Liver cancer incidence and mortality worldwide in 2008; http://globocan.iarc.fr/factsheets/cancers/liver.asp. 2011. |
17 | Giovannetti E, Pacetti P, Reni M, et al (2011). Association between DNA-repair polymorphisms and survival in pancreatic cancer patients treated with combination chemotherapy. Pharmacogenomics, 12, 1641-52. DOI ScienceOn |
18 | Han W, Kim KY, Yang SJ, et al (2012). SNP-SNP interactions between DNA repair genes were associated with breast cancer risk in a Korean population. Cancer, 118, 594-602. DOI ScienceOn |
19 | Hussain SP, Schwank J, Staib F, et al (2007). TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene, 26, 2166-76. DOI ScienceOn |
20 | Jung SW, Park NH, Shin JW, et al (2012). Polymorphisms of DNA repair genes in Korean hepatocellular carcinoma patients with chronic hepatitis B: possible implications on survival. J Hepatol, 57, 621-7. DOI ScienceOn |
21 | Lavanchy D (2004). Hepatitis B virus epidemiology, disease burden, treatment and current and emerging prevention and control measures. J Viral Hepat, 11, 97-107. DOI ScienceOn |
22 | Mahimkar MB, Samant TA, Kannan S, et al (2012). Polymorphisms in GSTM1 and XPD genes predict clinical outcome in advanced oral cancer patients treated with postoperative radiotherapy. Mol Carcinog, 51, E94-103. DOI ScienceOn |
23 | Mandal RK, Gangwar R, Kapoor R, et al (2012). Polymorphisms in base-excision & nucleotide-excision repair genes & prostate cancer risk in north Indian population. Indian J Med Res, 135, 64-71. DOI |
![]() |